Amgen | AMGN - Interessi Passivi Sul Debito





Interessi Passivi Sul Debito Cambiamento Data
AbbVie USD 688M 58M 2026-09
Agios Pharmaceuticals USD 1.11B 76.57M 2026-06
ALKERMES USD 25.92M 5.03M 2026-06
Amgen USD 95.64B 94.98B 2026-06
Biogen USD 72.6M 12.6M 2025-06
BioMarin Pharmaceutical USD 55.63M 7.67M 2026-09
Bristol-Myers Squibb USD 403M 4M 2026-09
Coherus Biosciences USD 2.25M 76K 2025-12
Eli Lilly USD 316M 201.3M 2026-09
Exelixis USD 23.4M 3.9M 2023-09
Genmab DKK 139M 129M 2026-06
Gilead Sciences USD 269M 22M 2026-09
GlaxoSmithKline GBP 219M 98M 2026-09
Glaxosmithkline GBP 264.74M 72.01M 2026-09
Incyte USD 605K 23K 2026-09
Ionis Pharmaceuticals USD 18M 1000K 2026-06
J&J USD 43M 25M 2026-03
Merck USD 525M 46M 2026-06
Moderna USD 10.96B 527M 2026-06
Neurocrine Biosciences USD 300K 2.6M 2026-09
Novartis USD 468M 6M 2026-09
Novartis USD 281M 8M 2025-09
Pfizer USD 667M 4M 2026-06
PTC Therapeutics USD 3.21B 42.76M 2026-09
Puma Biotechnology USD 3.37M 11K 2024-06
Regeneron Pharmaceuticals USD 11M 1.9M 2026-06
Roche Holding CHF 304M 7.5M 2025-06
Sanofi EUR 222M 65M 2026-09
Sarepta Therapeutics USD 21.51M 205K 2026-06
Takeda JPY 63.38B 466M 2026-09
Teva Pharmaceutical Industries USD 195M 21M 2026-06
Ultragenyx Pharmaceutical USD 22M 1000K 2026-06
Vertex Pharmaceuticals USD 36M 32.7M 2026-09